Backing Its Medtronic Deal, Orchestra BioMed Closes Series D to the Tune of $110M

Orchestra BioMed, which positions risk-reward sharing partnerships to help speed pivotal technologies to market for patients, has strung together a handful of new deals. Its machinations will be bolstered by its recently closed Series D financing totaling $110 million...